Dr. Reddy’s selects AWS to Develop Affordable Pharmaceutical Therapies for Patients Worldwide

Business MInutes

Amazon Web Services (AWS), an Amazon.com company, today announced that Dr. Reddy’s Laboratories Limited (Dr. Reddy’s), an Indian multinational pharmaceutical company based in Hyderabad, has selected AWS as its preferred cloud provider to help provide access to affordable and innovative medicines. 

As part of the collaboration, the company has migrated it’s SAP platform entirely on to AWS. By centralizing the platform on the world’s leading cloud, Dr. Reddy’s will accelerate the development of new healthcare applications, grow its digital platform to help the organization serve more than 1.5 billion patients by 2030 around the world, and enable healthcare providers to better track the progress of patients.   

With AWS, Dr. Reddy’s aims to reduce application development time by 30%, improve internal operations, accelerate improvements in generic drug manufacturing processes, and drive new areas of innovation. The company is one of the first AWS customers to run its data center and disaster recovery workloads now from both the new AWS Asia Pacific (Hyderabad) Region and the AWS Asia Pacific (Mumbai) Region. This enables Dr. Reddy’s to ensure even greater continuity of its services by running applications across multiple highly available data centers in India.

#buttons=(Ok, Go it!) #days=(20)

Our website uses cookies to enhance your experience. Check Now
Ok, Go it!